AlertDue in 34 daysPublic health6 days ago · Oct 20, 2026Canada

Manitoba imaging departments face upcoming shortage of Draximage Gluceptate kits

Jubilant DraxImage reports its Draximage Gluceptate kit (calcium glucoheptonate / stannous chloride, 25 mg / 3 mg powder for intravenous solution, DIN 02342006) faces an anticipated Tier 3 critical shortage from a manufacturing disruption. The shortage is anticipated from Aug 15, 2026 and expected to run until Nov 30, 2026.

Gluceptate is used in nuclear medicine kidney imaging — imaging departments should plan around the anticipated gap.

Shortage expected to end: Nov 30, 2026 All deadlines

Ask about this brief

Answers are written by AI from this brief and can be wrong. Check the original source before you act.

2 free questions a day without an account. Members ask as often as they like, free.

Not medical, legal or immigration advice. Questions are kept anonymously to improve our briefs.

Read the original

Official source: Manitoba imaging departments face upcoming shortage of Draximage Gluceptate kits (opens in a new tab) — Health Product Shortages Canada

Public healthTodayCanada

Health risks identified for patients cycling or stopping GLP-1 weight loss drugs

GLP-1 drugs were designed and tested for long-term treatment of diabetes and obesity, but growing numbers of people are using them off-label for short-term weight loss — microdosing, cycling on and off, or brief stints before weddings. A Danish study found roughly half of adults stopped semaglutide for obesity within 12 months. Experts warn stopping can lead to weight regain and worsened heart health and blood pressure, and mouse research found cycling made them less effective. No guidance exists yet on stopping safely; a 16-week Toronto trial is comparing tapering off with stopping abruptly.

Patients are asking frontline workers about GLP-1s for quick weight loss — this explains the risks of stopping and cycling, and that there is no safe way to quit yet.

News source: CBC News (opens in a new tab)

AlertPublic healthTodayCanada

Ebola outbreak reaches 9800 cases as regional travel restrictions tighten

The Ebola outbreak in the Democratic Republic of Congo has passed 9,800 cases and 4,700 deaths since May, the deadliest in the country's history. A nurse was killed and a health worker severely injured on Saturday in Bafwasende while responding to an Ebola alert. A Ugandan-born Swiss woman, Nigeria's first case, was flown from Abuja to Switzerland on Monday; she is stable in Geneva, her husband is in isolation in Zurich, and Nigeria now has no cases. Kenya has nine cases, two fatal; Uganda now requires citizens returning from the DRC to quarantine 21 days at their own expense.

The deadliest Ebola outbreak in DRC history is now spreading across borders — frontline workers should know the travel and quarantine rules as cases reach Nigeria, Kenya and Uganda.

News source: CBC News (opens in a new tab)+1 more source

Due in 19 daysPublic healthYesterdayCanada

Accel Pharma reports upcoming two-week shortage of ondansetron 8 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 8 mg (ACCEL-ONDANSETRON ODT, DIN 02535327) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

Official source: Health Product Shortages Canada (opens in a new tab)